Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2026-01-01 @ 5:48 PM
Study NCT ID:
NCT05602935
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-28
First Post:
2022-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
Sponsor:
The Second Affiliated Hospital of Fujian Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-24
First Submit QC Date:
None
Study First Post Date:
2022-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-26
Last Update Post Date:
2023-09-28
Last Update Post Date Type:
ACTUAL